• Conference Proceeding

A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Citation

Odom, D., Brogan, A., Talbird, S. E., & Schenkel, B. (2013). A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis. In [16], pp. A112–A112. .

Abstract